Skip to main content

Table 2 Cytokine levels in patients with NHC, CHB and HBV-related cirrhosis (pg/mL)

From: Potential circulating biomarkers of circulating chemokines CCL5, MIP-1β and HA as for early detection of cirrhosis related to chronic HBV (hepatitis B virus) infection

Cytokines

NHC (n = 52)

CHB (n = 78)

HBV-related cirrhosis (n = 73)

P-values

CCL5

9335.99 (526.34–18,975.78)

11,729.47 (564.78–15,610.99)

4375.79 (890.92–14,658.46) ### ***

< 0.001

MIP-1β

80.45 (29.08–145.58)

75.77 (26.00–225.33)

49.3 (26.56–72.53) # *

< 0.01

MIP-1α

0.31 (0.18–2.15)

0.34 (0.18–3.21)

0.29 (0.18–0.49)

ns

IL-2

11.91 (4.32–198.55)

10.86 (5.09–112.64)

12.26 (6.62–271.74)

ns

IL-5

2.87 (1.15–8.34)

3.50 (1.50–7.02)

3.18 (1.24–6.08)

ns

IL-4

1.11 (0.81–3.88)

1.34 (0.81–5.65)

1.25 (0.89–1.84)

ns

IL-6

9.02 (4.08–112.55)

8.80 (4.58–88.19)

9.23 (4.28–162.78)

ns

IL-7

1.35 (0.91–8.33)

1.40 (0.98–9.04)

1.29 (0.94–3.25)

ns

IL-8

54.47 (8.54–974.35)

47.13 (9.60–3658.40)

27.20 (9.89–254.21)

ns

IL-10

4.94 (2.15–98.49)

4.80 (2.30–60.45)

4.10 (2.20–330.67)

ns

IL-1β

0.16 (0.09–1.11)

0.15 (0.09–1.69)

0.14 (0.09–0.29)

ns

IL-12

4.18 (2.85–158.63)

3.99 (2.55–272.81)

5.63 (2.79–391.44)

ns

IL-13

1.18 (0.89–2.44)

1.09 (0.83–2.64)

1.26 (0.91–2.38)

ns

IL-17

38.55 (20.63–99.65)

40.92 (20.99–184.84)

37.34 (21.97–93.25)

ns

G-CSF

18.88 (13.70–65.23)

17.80 (13.70–71.55)

20.78 (13.70–40.07)

ns

GM-CSF

45.26 (15.26–19.48)

46.79 (19.00–280.83)

54.43 (14.54–150.88)

ns

IFN-γ

35.12 (20.99–53.54)

33.83 (20.81–58.76)

30.63 (20.81–55.70)

ns

MCP-1

20.07 (9.02–189.64)

18.60 (9.02–203.89)

13.97 (9.02–30.28)

ns

TNF-α

8.18 (6.99–84.57)

8.11 (6.25–73.31)

8.16 (6.87–96.67)

ns

  1. #: vs NHC P < 0.05, ###: vs NHC P < 0.001,*: vs CHB P < 0.05, ***: vs CHB P < 0.001, ns no significance